Objective: To determine the elastic modulus of the periodontal ligament (PDL). Materials and Methods: This study was carried out on eight human maxillary jaw segments containing central incisors. Displacements were measured under load using a laser sensing system, electronic speckle pattern interferometry (ESPI). Subsequently, finite element models presenting the same individual geometry as the respective autopsy material were developed by the software of Mimics and Ansys, based on scanning data from micro computed tomography (micro CT), to simulate tooth mobility numerically under the same force systems as were used in the experiment. Numerical force/deflection curves obtained from the models were fitted to the experimental curves by repeatedly calculating theoretical tooth deflections and varying the elasticity parameters of the human PDL. Results: A bilinear material parameter set was assumed to simulate tooth deflections. Mean values of E1 = 0.04 MPa, E2 = 0.16 MPa, and ultimate strain of ɛ12 = 7.3% were derived for the elastic behavior of the PDL. Conclusion: Force/deflection curves from the measurements showed a significant nonlinear behavior of elastic stiffness of the PDL. A bilinear material parameter set was suitably assumed to be a description of nonlinear properties of the PDL.
Facial jaw muscle is involved in the occurrence, development, treatment and maintenance of maxillofacial deformities. The structure and function of this tissue can be altered by changes in external stimuli, and orthodontists can regulate its reconstruction using orthopedic forces. The PI3K/Akt signaling pathway is most well‑known for its biological functions in cell proliferation, survival and apoptosis. In the present study, the effects of the PI3K/Akt signaling pathway in cyclic stretch‑induced myoblast apoptosis were investigated. For this purpose, L6 rat myoblasts were cultured under mechanical stimulation and treated with the PI3K kinase inhibitor, LY294002, to elucidate the role of the PI3K/Akt signaling pathway. Cells were stained with Hoechst 33258 to visualize morphological changes and apoptosis of myoblasts, and western blotting was performed to detect expression of Akt, phosphorylated (p)‑Akt (Ser473), glycogen synthase kinase 3β (GSK‑3β) and p‑GSK‑3β (Ser9). After addition of PI3K inhibitor, the expression of total Akt and GSK‑3β did not significantly differ among groups; however, the levels of p‑Akt and p‑GSK‑3β were lower in inhibitor‑treated groups than in those treated with loading stress alone. In addition, the rate of apoptosis in myoblasts subjected to cyclic stretch increased in a time‑dependent manner, peaking at 24 h. Collectively, it was also demonstrated that the PI3K/Akt/GSK‑3β pathway plays an important role in stretch‑induced myoblast apoptosis.
Thus far, there are more than known 150 modifications to RNA,in which common internal modifications of mRNA include N6-Methyladenosine(m6A), N1-methyladenosine(m1A) and 5-methylcytosine (5-mC). Among them, m6A RNA modification is one of the highest abundance modifications in eukaryotes, regulating mechanisms controlling gene expression at the molecular level. As an invertible and dynamic epigenetic marker, m6A base modification influences almost all vital biological processes, cellular components, and molecular functions. Once the m6A modification process is abnormal, a series of diseases -including cancer, neurological diseases, and growth disorders -will be caused. Besides, several base modification activities also have been existed by non-coding RNAs, for instance, microRNAs (miRNAs), and circular RNAs (circRNAs) ,long non-coding RNAs (lncRNAs), which dynamically regulated during Bone and cartilage Pathophysiology processes. Therefore,it has now been clear that dynamic modification on coding RNAs and non-coding RNAs represents a completely new way to modulate genetic information. In this review, we highlight up-to-date progress and applications of N6-methyladenosine (m6A) RNA modification in bone and cartilage pathophysiology, and discuss the pathological roles and underlying molecular mechanism of m6A modifications in osteoarthritis and osteoporosis pathogenesis.